Simplex Trading’s Viracta Therapeutics VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,500
Closed -$6K – 10714
2022
Q3
$6K Sell
1,500
-200
-12% -$847 ﹤0.01% 8703
2022
Q2
$6K Buy
1,700
+200
+13% +$570 ﹤0.01% 8767
2022
Q1
$7K Sell
1,500
-900
-38% -$2.71K ﹤0.01% 9227
2021
Q4
$8K Buy
2,400
+1,400
+140% +$7.47K ﹤0.01% 9243
2021
Q3
$12K Hold
1,000
– – ﹤0.01% 8844
2021
Q2
$11K Buy
1,000
+998
+49,900% +$10K ﹤0.01% 9061
2021
Q1
$1K Buy
+2
New +$21 ﹤0.01% 8593
2020
Q1
– Sell
-1
Closed -$1K – 8432
2019
Q4
$1K Hold
1
– – ﹤0.01% 7145
2019
Q3
$2K Hold
1
– – ﹤0.01% 6975
2019
Q2
$1K Sell
1
-5
-83% -$193 ﹤0.01% 6924
2019
Q1
$27K Buy
+6
New +$136 ﹤0.01% 5507
2018
Q4
– Sell
-6
Closed -$40K – 7977
2018
Q3
$40K Buy
+6
New +$456 ﹤0.01% 5385
2018
Q2
– Sell
-1
Closed -$89 – 7218
2018
Q1
$7K Buy
+1
New +$171 ﹤0.01% 4388
2017
Q1
– Sell
-1
Closed -$1K – 6910
2016
Q4
$1K Hold
1
– – ﹤0.01% 5557
2016
Q3
$2K Buy
+1
New +$141 ﹤0.01% 5091
2016
Q2
– Hold
0
– – – 4134
2016
Q1
– Hold
0
– – – 3839
2015
Q4
– Hold
0
– – – 3920
2015
Q3
– Hold
0
– – – 4445
2015
Q1
– Sell
-1
Closed -$2K – 5731
2014
Q4
$2K Buy
+1
New +$451 ﹤0.01% 3849

Simplex Trading's VIRX Position: Q2 2025 in Review

Simplex Trading sold out of Viracta Therapeutics (VIRX) in Q2 2025, closing a stake of 400 shares.

Simplex Trading first reported a position in VIRX in Q3 2015 and held it in 23 quarters. The position peaked at $96K in Q1 2017. 0 funds tracked by Wall St. Rank hold VIRX as of Q2 2025.

  • Simplex Trading reported no remaining Viracta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 400 Viracta Therapeutics shares in Q2 2025.
  • Simplex Trading first reported a position in Viracta Therapeutics in Q3 2015 and held it in 23 quarters.
  • Simplex Trading's Viracta Therapeutics position peaked at $96K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Viracta Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.